Pharmaceutical Regulation Tightening Expands Blister Film Specification
Pharmaceutical contract packagers are increasingly specifying thermoforming film with validated gauge consistency for child-resistant and moisture barrier blister applications, since regulatory compliance documentation now shapes film procurement decisions as directly as cost once did on its own. Roughly 18 percent of new pharmaceutical blister specifications since 2023 call for certified gauge consistency documentation, reflecting growing brand recognition that validated thermal forming performance increasingly determines which converters win long-term contract packaging agreements. Regulatory tightening across North American and European child-resistant packaging standards is compounding this specification shift faster than extrusion capacity plans anticipated two years ago. Adjacent demand is captured in the ionising air gun market, which MMA expects to grow from USD 0.4 billion in 2025 to USD 0.7 billion by 2036.
Market Impact: Packaging volume grew 5% in 2024








